Gain Therapeutics Financial Overview
Gain Therapeutics's market cap is currently $155.77M. The company's EPS TTM is $-0.15; its P/E ratio is -3.52; Gain Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
